参考文献：

［1］李丽，贾继东，王宝恩.血色病的欧美诊断治疗规范［J］.胃肠病学和肝病学杂志，2008，17（1）：l-3.

［2］EDOUARD,BARDOU-JACQUET,JEFF,et al.Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis［J］.Journal of Hepatology,2015.

［3］吕婷霞，黄坚.我国人群遗传性血色病基因突变特点分析［J］.临床肝胆病杂志，2016，32（8）：1571-1574.

［4］赵新颜，何志颖，刘立伟，等.45 例原发性与继发性血色病临床病理特点对比研究［J］.传染病信息，2019，32（2）：127-131.

［5］蒲艳，杨晋辉，杨婧，等.血色病并重度黄疸1 例［J］.中华肝脏病杂志，2014，22（11）：875-877.(https://www.daowen.com)

［6］NJAJOU OT,ALIZADEH BZ,DUIJN C.Is genetic screening for hemochromatosis worthwhile［J］.European Journal of Epidemiology,2004,19（2）:101-108.

［7］PIETRANGELO A.Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents［J］.J Clin Invest,1995,95:1824-1831.

［8］MONTOSI G.Hepatic stellate cells are not subjected to oxidant stress during iron-induced fibrogenesis in rodents.Hepatology,1998,27:1611-1622.

［9］BACON B R,ADAMS P C,KOWDLEY K V,et al.Diagnosis and management of hemochromatosis:2011 practice guideline by the American Association for the study of liver diseases［J］.Hepatology,2011,54（1）:328-343.

（吴旭玮 甘巧蓉 王斌 林昭旺 黄祖雄）